Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2014-07-30 to 2014-08-18
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- (July, 2010)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- (May, 2008)
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- (March, 2003)
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/J, inbred, SPF-Quality
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: Young adult animals (approx. 10 weeks old)
- Weight at study initiation: variation was within +/- 20% of the sex mean.
- Housing: Makrolon cages (MIII type; height 18 cm) containing sterilised sawdust as bedding material (Lignocel S 8-15, JRS - J.Rettenmaier & Söhe GmbH + CO. KG, Rosenberg, Germany). Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) and shelters (disposable paper corner home, MCORN 404, Datesand Ltd, USA) were supplied as cage-enrichment. On Day 6, the animals were group housed in Makrolon MII type cages with a sheet of paper instead of sawdust and cage enrichment.
- Diet (e.g. ad libitum): pelleted rodent diet (SM R/M-Z from SNIFF^R Spezialdiaten GmbH, Soest, Germany), ad libitum
- Water (e.g. ad libitum): tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C
- Humidity (%): 40 to 70%
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12-hour light/12-hour dark - Vehicle:
- other: Water (Elix, Millipore S.A.S., Molsheim, France) with 1% pluronic L92 (BASF, New Jersey, USA).
- Concentration:
- 10%, 25%, 50% w/w
- No. of animals per dose:
- five females per group
- Details on study design:
- RANGE FINDING TESTS:
- Irritation: no irritation determined
- Lymph node proliferation response: not examined
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: LLNA
- Criteria used to consider a positive response: if the Stimulation Index (SI) is = 3
TREATMENT PREPARATION AND ADMINISTRATION:
- Days 1, 2, 3: The dorsal surface of both ears was topically treated (25 µL/ear) with the test substance concentration, at approximately the same time on each day. The concentrations were stirred with a magnetic stirrer or mixed with a vortex mixer (main 50% Days 2 and 3) immediately prior to dosing. - Positive control results:
- not performed
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Mean DPM+-SEM: control: 608+-80 Test item 10%: 407+-78 Test item 25%: 516+-82 Test item 50%: 552+-51
- Key result
- Parameter:
- SI
- Value:
- 1
- Test group / Remarks:
- 5 animals/control
- Remarks on result:
- other: Mean SI+-SEM: control: 1.0+-0.2
- Key result
- Parameter:
- SI
- Value:
- 0.7
- Test group / Remarks:
- 5 animals/10% test item
- Remarks on result:
- other: Mean SI+-SEM: Test item 10%: 0.7+-0.2
- Key result
- Parameter:
- SI
- Value:
- 0.8
- Test group / Remarks:
- 5 animals/25% test item
- Remarks on result:
- other: Mean SI+-SEM: Test item 25%: 0.8+-0.2
- Key result
- Parameter:
- SI
- Value:
- 0.9
- Test group / Remarks:
- 5 animals/50% test item
- Remarks on result:
- other: Mean SI+-SEM: Test item 50%: 0.9+-0.1
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Based on the study results, Lithium salt of branched-aliphatic dicarboxylic acid would not be regarded as a skin sensitizer according to the recommendations made in the test guidelines.
- Executive summary:
Assessment of Contact Hypersensitivity to Lithium salt of branched-aliphatic dicarboxylic acid in the Mouse (Local Lymph Node Assay).
The study was carried out based on the guidelines described in: OECD, Section 4, Health Effects, No.429 (2010), EC, No 440/2008; B42: "Skin Sensitisation: Local Lymph Node Assay", EPA, OPPTS 870.2600 (2003) “Skin Sensitisation”.
Test substance concentrations selected for the main study were based on the results of a pre-screen test.
In the main study, three experimental groups of five female CBA/J mice were treated with test substance concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the ears. Five vehicle control animals were similarly treated, but with vehicle alone (water (Elix) with 1% pluronic L92).
Three days after the last exposure, all animals were injected with 3H-methyl thymidine and after five hours the draining (auricular) lymph nodes were excised and pooled for each animal. After precipitating the DNA of the lymph node cells, radioactivity measurements were performed. The activity was expressed as the number of Disintegrations Per Minute (DPM) and a stimulation index (SI) was subsequently calculated for each group.
No irritation of the ears was observed in the animals except for the very slight erythema noted for one animal at 50% (right ear only) on Day 3. Bald spots behind the ears were noted for all animals at 50% from Day 3 onwards.
All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size. No macroscopic abnormalities of the surrounding area were noted for any of the animals.
Mean DPM/animal values for the experimental groups treated with test substance concentrations 10, 25 and 50% were 407, 516 and 552 DPM, respectively. The mean DPM/animal value for the vehicle control group was 608 DPM. The SI values calculated for the substance concentrations 10, 25 and 50% were 0.7, 0.8 and 0.9, respectively.
Since there was no indication that the test substance elicited a SI = 3 when tested up to 50%, Lithium salt of branched-aliphatic dicarboxylic acid was not considered to be a skin sensitiser.
The six-month reliability check with Alpha-hexylcinnamaldehyde indicates that the Local Lymph Node Assay as performed at WIL Research Europe is an appropriate model for testing for contact hypersensitivity.
Based on these results, Lithium salt of branched-aliphatic dicarboxylic acid would not be regarded as a skin sensitiser according to the recommendations made in the test guidelines. The test substance does not have to be classified for sensitisation by skin contact according to the Globally Harmonised System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments) and the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments).
Reference
Pre-screen test:
No irritation and no signs of systemic toxicity were observed in the animals except for the very slight erythema noted for both animals at 50% on Day 3. Bald spots behind the ears were noted for both animals at 50% from Day 4 onwards. Yellow test substance remnants were present on the dorsal surface of the ears of both animals at 50% (Days 3, 4 and/or 5), which did not hamper scoring of the skin reactions. Variations in ear thickness during the observation period were less than 25% from Day 1 pre-dose values. Based on these results, the highest test substance concentration selected for the main study was a 50% concentration.
Main study:
Skin reactions / Irritation
No irritation of the ears was observed in the animals except for the very slight erythema noted for one animal at 50% (right ear only) on Day 3. Bald spots behind the ears were noted for all animals at 50% from Day 3 onwards. White test substance remnants were present on the dorsal surface of the ears of all animals at 50% (Days 1-3), which did not hamper scoring of the skin reactions.
Systemic toxicity:
No mortality occurred and no clinical signs of systemic toxicity were observed in the animals of the main study. Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.
Macroscopy of the auricular lymph nodes and surrounding area:
All auricular lymph nodes of the animals of the experimental and control groups were considered normal in size. No macroscopic abnormalities of the surrounding area were noted for any of the animals.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
The contact hypersensitivity of Lithium salt of branched-aliphatic dicarboxylic acid was evaluated in a reliable study according to the appropriate standard test methods EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay), OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) and EPA, OPPTS 870.2600 (2003) “Skin Sensitization”.
Three experimental groups of five female CBA/J mice were treated with test substance concentrations of 10, 25 or 50% w/w on three consecutive days, by open application on the ears. Measurements were performed three days after the last exposure.
No irritation of the ears was observed in the animals except for the very slight erythema noted for one animal at 50% (right ear only) on Day 3. Bald spots behind the ears were noted for all animals at 50% from Day 3 onwards.
Based on these results, the test substances would not be regarded as a skin sensitiser according to the recommendations made in the test guidelines. The test substance does not have to be classified for sensitisation by skin contact according to the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) of the United Nations (2011) (including all amendments) and the Regulation (EC) No 1272/2008 on classification, labelling and packaging of substances and mixtures (including all amendments).
Migrated from Short description of key information:
Lithium salt of branched-aliphatic dicarboxylic acid was tested for contact hypersensitivity to mice according to OECD guideline No. 429: " Skin Sensitisation: Local Lymph Node Assay ", adopted July, 2010 and Commission regulation (EC) No. 440/2008 of 30 May 2008, Part B.42: “Skin Sensitisation: Local Lymph Node Assay”, Publication No. L142.
The test substance was not regarded as a skin sensitiser under the test conditions.
Justification for selection of skin sensitisation endpoint:
The study was conducted under GLP conditions according to OECD guideline 429 and matched the requirements of Annex 7 of the REACH legislation.
Justification for classification or non-classification
No sensitising effect was observed in the Local Lymph Node Assay for skin sensitisation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.